Bloodless blood typing training kit

Claim 2

A blood typing training kit including red blood cell models and anti-serum models comprising: a support means having an A red blood cell model with an anti-A serum model counterpart and a B red blood cell model with an anti-B serum model counterpart wherein each of said A/anti-A and B/anti-B combinations are selected from the group consisting of: a) the red blood cell model of a natural or synthetic water-insoluble polymer bound with a saccharide selected from the group consisting of mannose, glucose, maltose, isomaltose, gentiobiose, maltotriose and the antiserum model comprising one or two or more phytohemagglutinins in the third group of Makela's classification; b) the red blood cell model of a natural or synthetic water-insoluble polymer bound with galactose or lactose and the antiserum model comprising one or two or more phytohemagglutininins in the second group of Makela's classification; c) the red blood cell model of a water-insoluble saccharide in alkaline suspension and the antiserum model of boric acid containing liquid; and d) the red blood cell model of a natural or synthetic water-insoluble polymer bound with protein A or G and the antiserum model of immunoglobulin G.

Claim 3

The kit of claim 1, wherein said A/anti-A and B/anti-B combinations comprise: a) the red blood cell model of a natural or synthetic water-insoluble polymer bound with a saccharide selected from the group consisting of mannose, glucose, maltose, isomaltose, gentiobiose, maltotriose and the antiserum model comprising one or two or more phytohemagglutinins in the third group of Makela's classification; and b) the red blood cell model of a natural or synthetic water-insoluble polymer bound with galactos or lactose and the antiserum model comprising one or two or more phytohemagglutinins in the second group of Makela's classification, respectively; and said kit further comprises: an O red blood cell model selected from the group consisting of: a) a natural or synthetic water-insoluble polymer, b) an epoxidated form of a natural or synthetic water-insoluble polymer, and c) a polymer bound with a saccharide selected from the group consisting of N-acetylgalacyosamine, N-acetylglycosamine and N-acetylmannosamine; and an AB red blood cell model comprising a natural or synthetic polymer bound with a saccharide selected from the group consisting of mannose, glucose, maltose, isomaltose, and maltotriose, and also bound with a saccharide selected from the group consisting of galactose and mannose.

Claim 4

The kit of claim 1, wherein said A/anti-A and B/anti-B combinations comprise: a combination selected from the group consisting of: a) the red blood cell model of a natural or synthetic water-insoluble polymer bound with a saccharide selected from the group consisting of mannose, glucose, maltose, isomaltose, gentiobiose, maltotriose and the antiserum model comprising one or two or more phytohemagglutinins in the third group of Makela's classification, or b) the red blood cell model of a natural or synthetic water-insoluble polymer bound with galactose or lactose and the antiserum model comprising one or two or more phytohemagglutinins in the second group of Makela's classification; and c) the red blood cell model of a water-insoluble saccharide in alkaline suspension and the antiserum model of boric acid containing liquid; and said kit further comprises: an O red blood cell model comprising a natural or synthetic water-insoluble polymer in acidic suspension, and an AB red blood cell model comprising an alkaline suspension of a natural or synthetic polymer bound with a saccharide selected from the group consisting of mannose, glucose, maltose, isomaltose and maltotriose when group (a) is used as an A/anti-A combination and an alkaline suspension of a natural or synthetic polymer bound with a saccharide selected from the group consisting of galactose and mannose when group (b) is used as an A/anti-A combination.

Claim 5

The kit of claim 1, wherein said A/anti-A and B/anti-B combinations comprise: a combination selected from the group consisting of: a) the red blood cell model of a natural or synthetic water-insoluble polymer bound with a saccharide selected from the group consisting of mannose, glucose, maltose, isomaltose, gentiobiose, maltotriose and the antiserum model comprising one or two or more phytohemagglutinins in the third group of Makela's classification, or b) the red blood cell model of a natural or synthetic water-insoluble polymer bound with galactose or lactose and the antiserum model comprising one or two or more phytohemagglutinins in the second group of Makela's classification; and d) the red blood cell model of a natural or synthetic water-insoluble polymer bound with protein a or G and the antiserum model of immunoglobulin G, respectively; and said kit further comprises: an O red blood cell model selected from the group consisting of: a) a natural or synthetic water-insoluble polymer, b) an epoxidated form of a natural or synthetic water-insoluble polymer, and c) a polymer bound with a saccharide selected from the group consisting of N-acetylgalactosamine, N-acetylglucosamine and N-acetylmannosamine; and an AB red blood cell model comprising a natural or synthetic water-insoluble polymer bound with a saccharide selected from the group consisting of mannose, glucose, maltose, isomaltose, gentiobiose and maltotriose when group (a) is used as an A/anti-A combination and a natural or synthetic water-insoluble polymer bound with a saccharide selected from the group consisting of galactose and lactose and also bound with a protein selected from the group consisting of protein A and protein G when group (b) is used as an A/anti-A combination.

Claim 6

The kit of claims 1, 2, 3, or 4, wherein said natural or synthetic water-insoluble polymer is selected from the group consisting of agarose, Sepharose, Sephadex, cellulofine, alginate, tamarind, polysaccharide, gelatin and xanthan gum.